Venous thromboembolism is a major cause of morbidity and mortality in the health system, and all patients should be assessed to determine their level of risk. The latest prophylactic treatment guidelines are presented here.
Cindy Le, PharmD
Advertisement
Articles by Cindy Le, PharmD
Advertisement
Latest Updated Articles
- Roundup: Formulary Considerations for VTE
Published: August 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
Low-Dose Aspirin Linked to Lower Cardiovascular Risk in Type 2 Diabetes
5
